Literature DB >> 2077853

1.32 microns Nd:YAG laser during neurosurgical procedures experience with about 70 patients operated on with the MC 2100 unit.

F X Roux1, B Devaux, L Merienne, C Cioloca, J P Chodkiewicz.   

Abstract

The authors present their clinical experience with 1.32 microns Nd-YAG Laser. After a series of experimental studies which demonstrated the adaptability of such a wavelength to central nervous surgery, they used such a Laser during current neurosurgical procedures. The MC 2100 unit combines two wavelengths 1.32 microns and 1.06 microns, and two emission modes: continuous wave (c.w.) and pulsed. This Laser has been used during 70 procedures: 54 supra-tentorial, 8 infra-tentorial, 5 intra-spinal, 3 intra-orbital, 600 microns and 400 microns fibers were preferred in most cases, either with a telescopic light handpiece or- less often--with a focussing handpiece. The quality of vaporization--close to that of CO2 Laser- and of haemostasis-close to that of 1.06 microns Nd-YAG Laser-makes this 1.32 microns wavelength very suitable for neurosurgery. The manoeuverability due to the optic fibers is most interesting. Furthermore, such a Laser should have in the near future large applications in stereotactic and/or endoscopic neurosurgery.

Entities:  

Mesh:

Year:  1990        PMID: 2077853     DOI: 10.1007/BF01405796

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  7 in total

1.  Biomedical utility of 1.34 mum nd: yag laser radiation.

Authors:  L F Stokes; D C Auth; D Tanaka; J L Gray; C Gulacsik
Journal:  IEEE Trans Biomed Eng       Date:  1981-03       Impact factor: 4.538

2.  The Nd:YAG laser in neurological surgery.

Authors:  J Takeuchi; H Handa; W Taki; T Yamagami
Journal:  Surg Neurol       Date:  1982-08

3.  Computer-assisted stereotactic microsurgery for the treatment of intracranial neoplasms.

Authors:  P J Kelly; G J Alker; S Goerss
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

4.  Intracranial haemostasis with a neurosurgical CO2-laser unit.

Authors:  F X Roux; J P Constans; J P Chodkiewicz
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

5.  The Nd:YAG laser in neurosurgery. Part 2. Clinical studies: an adjunctive measure for hemostasis in resection of arteriovenous malformations.

Authors:  R E Wharen; R E Anderson; T M Sundt
Journal:  J Neurosurg       Date:  1984-03       Impact factor: 5.115

6.  Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study.

Authors:  L M Auer; W Deinsberger; K Niederkorn; G Gell; R Kleinert; G Schneider; P Holzer; G Bone; M Mokry; E Körner
Journal:  J Neurosurg       Date:  1989-04       Impact factor: 5.115

7.  Treatment of colloid cysts of the third ventricle by stereotaxic microsurgical laser craniotomy.

Authors:  C D Abernathey; D H Davis; P J Kelly
Journal:  J Neurosurg       Date:  1989-04       Impact factor: 5.115

  7 in total
  2 in total

Review 1.  Experimental and clinical standards, and evolution of lasers in neurosurgery.

Authors:  B C Devaux; F X Roux
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Image-guided resection of glioblastoma in eloquent brain areas facilitated by laser surface thermal therapy: clinical outcomes and long-term results.

Authors:  Artem Rozumenko; Valentyn Kliuchka; Volodymir Rozumenko; Vera Semenova; Sergii Kolesnyk; Zoja Fedorenko
Journal:  Neurosurg Rev       Date:  2018-01-22       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.